Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F18%3A10375413" target="_blank" >RIV/00216208:11130/18:10375413 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/18:10375413

Výsledek na webu

<a href="https://doi.org/10.1002/pbc.26861" target="_blank" >https://doi.org/10.1002/pbc.26861</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/pbc.26861" target="_blank" >10.1002/pbc.26861</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology

Popis výsledku v původním jazyce

Adolescents and young adults (AYA) comprise a specific group of oncology patients with a distinct biological and epidemiological spectrum of central nervous system neoplasms. It has been well documented that they differ clinically, especially in relation to prognosis and chemotherapy tolerance; however, the underlying reasons for this are unclear. Recent advances in the genomics of both childhood and adult brain tumors have provided new explanations and insights into the previously described age-dependent heterogeneity. Herein, we summarize the current state of the AYA population in neuro-oncology, specifically how biological advances can help personalize therapy for this unique group of patients.

Název v anglickém jazyce

Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology

Popis výsledku anglicky

Adolescents and young adults (AYA) comprise a specific group of oncology patients with a distinct biological and epidemiological spectrum of central nervous system neoplasms. It has been well documented that they differ clinically, especially in relation to prognosis and chemotherapy tolerance; however, the underlying reasons for this are unclear. Recent advances in the genomics of both childhood and adult brain tumors have provided new explanations and insights into the previously described age-dependent heterogeneity. Herein, we summarize the current state of the AYA population in neuro-oncology, specifically how biological advances can help personalize therapy for this unique group of patients.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30204 - Oncology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Pediatric Blood and Cancer

ISSN

1545-5009

e-ISSN

—

Svazek periodika

65

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

—

Kód UT WoS článku

000418416400059

EID výsledku v databázi Scopus

2-s2.0-85038563787